The treatment of brain disorders is particularly challenging due to the presence of a variety
of formidable obstacles to deliver drugs selectively and effectively to the brain. Blood-brain …

The treatment of brain disorders is the greatest challenge because of a variety of formidable
obstacles in effective drug delivery and maintaining therapeutic concentrations in the brain …

Delivery of therapeutics to the central nervous system for treating psychiatric and
neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease, is a …

Many drugs are not being effectively and efficiently delivered using conventional drug
delivery approach to brain or central nervous system (CNS) due to its complexity. The brain …

Now a day's intranasal (in) drug delivery is emerging as a reliable method to bypass the
blood–brain barrier (BBB) and deliver a wide range of therapeutic agents including both …

Background Cranial nerve-related diseases such as brain tumors, Alzheimer's disease, and
epilepsy are serious diseases that continue to threaten human. Brain-related diseases are …

The treatment of central nervous system (CNS) disorders is particularly challenging because
of a variety of formidable barriers to effective and persistent delivery of therapeutic …

Present review highlights the potential of nasal mucosa as an administration route for
targeting the central nervous system (CNS), in particular, the brain. Delivery of drugs to the …

Blood-brain barrier (BBB) provides restrictions for the transportation of various therapeutic
agents to the brain. Efforts to directly target the brain by olfactory as well as trigeminal nerve …

Intranasal drug delivery occupies the prime place against newer drug delivery systems to
transport drugs to CNS bypassing the blood brain barrier. Recent advances in molecular …